Alzheimer’s and Dementia

A critical combination for Alzheimer's patients

Programs that Save Lives

Alzheimer’s disease is an irreversible, progressive brain disorder that destroys memory and other critical brain functions. It is the sixth leading cause of death among adults. As scientists actively research a cure, patients and families are managing the disease’s devastating effects. At Barrow, our dedicated doctors and scientists provide hope to patients and caregivers battling the disease by integrating research with compassionate care. See what we achieved in the last fiscal year by downloading the Impact Report below.

FY21 Alzheimer’s and Memory Disorders Stewardship Report
FY21 Alzheimer’s and Memory Disorders Stewardship Report
Download Brochure
Every 0 seconds someone in the US develops Alzheimer’s
More than 0 Americans live with Alzheimer's
Deaths from Alzheimer's have increased by 0 since year 2000

The Alzheimer’s and Memory Disorders Program’s supportive, compassionate and cutting-edge approach attracts patients from around the world and offers hope to families.

An uncompromising commitment to ending an epidemic

Doctors and researchers at Barrow are relentlessly committed to finding a cure for Alzheimer’s because:

  • Alzheimer’s is a national crisis, expected to affect more than 16 million people by 2050.
  • It is the only top 10 cause of death that cannot be prevented or cured.
  • There is currently no single test to accurately diagnose Alzheimer’s.

By combining cutting edge research with high quality care, we can make Alzheimer’s a manageable condition, rather than a death sentence, within ten years. Give now.

Changing the lives of patients with Alzheimer’s and memory disorders

At Barrow we are uniquely positioned to lead research into new Alzheimer’s treatments due to our strong research culture, critical mass of talented faculty and infrastructure focused on innovative studies.

Our team is driven by a passion for the cause. Elliott Mufson, PhD, a highly respected Alzheimer’s Disease researcher, lost his father to the condition and has since committed his work to identifying its causes. He is a pioneer in the application of single cell gene array technology during the disease’s progression, with his research leading to a clinical trial aimed at rejuvenating brain cells lost early in the development of Alzheimer’s.

Dr. Mufson and other leading researchers have grown and developed Barrow’s clinical trials program. Current research includes:

  • Prevention studies
  • Imaging research to better understand the disease
  • Treatment studies focused on slowing the progression of illness
The Layman family
Patient Story

A surprising and hopeful dementia diagnosis

Meet Jay Layman and learn how our team helped him navigate his Lewy body dementia diagnosis at just 51 years old.

View Story